SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-000602
Accepted
2024-03-06 00:15:07
Documents
1
Effectiveness Date
2024-03-05
Registration Form
POS AM
Reference AccNo

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 608
  Complete submission text file 9999999995-24-000602.txt   2001
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
PHAXIAM Therapeutics S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-259690 | Film No.: 24724271
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)